Mazars assisted Adlai Nortye (ANL) on the IPO in Nasdaq (29 September 2023)

A big congratulations to Adlai Nortye (NASDAQ: ANL) successfully listed in Nasdaq on 29 September 2023! Mazars is honoured to be one of the professional services firms that assisted Adlai Nortye to list in the United States through the combined efforts of our offices in the United States, Mainland China, and Hong Kong. It is a significant case to prove that Mazars works as one integrated team to deliver exceptional and tailored services to our clients.

Our Partners, Paul She and Sam Tsoi from Mazars in Hong Kong attended the ceremony of IPO in Hangzhou to witness this milestone.

Adlai Nortye is the first Chinese company to successfully launch an IPO in the US since the implementation of the new filing rules on 31 March this year. Adlai Nortye operates as a Cayman Islands-incorporated company with subsidiaries in the US and China. Its primary focus is to facilitate the development and commercialisation of innovative medicines through the licensing-in model.

Adlai-Nortye-1.jpeg
Adlai-Nortye-2.jpeg
Adlai-Nortye-3.jpeg
Adlai-Nortye-4.jpg